PhaseV
Clinical Trial Optimization
11 open roles Clinical Trial Optimization Cambridge, United States 61 employees $65M raised Est. 2023
Accel
Insight Partners
Viola Ventures
Exor Ventures
LionBird
Gershon Capital
About PhaseV
PhaseV focuses on ML-driven adaptive trials and clinical development optimization to accelerate drug discovery.
PhaseV is listed on Rocketlist with 11 active roles. The company is categorized as Clinical Trial Optimization in BioTech. PhaseV is at Series A stage, with a B2B business model, headquartered in Cambridge, United States. PhaseV was founded in 2023 and has 61 employees. PhaseV has raised $65M. Active roles are refreshed daily from public hiring sources.
Open roles at PhaseV (11)
Senior Director of Business Development
PhaseV · Cambridge, United States · Director
Sales & Account Management
Strategy and Market Intelligence Intern
PhaseV · Cambridge, United States · Intern
Operations & Strategy